 |
|
| FriendFeed is the easiest way to share online. Learn more » |
Regenerative Medicine
Geron plans to use ESC-derived dendritic cells in v 2.0 of its GRNVAC1 product currently in ph II trials for AML - http://www.genengnews.com/news...
July 6
from Twitter
- Comment
- Like
- Share